These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34192267)

  • 1. Innate immunology in COVID-19-a living review. Part I: viral entry, sensing and evasion.
    Coveney C; Tellier M; Lu F; Maleki-Toyserkani S; Jones R; Bart VMT; Pring E; Alrubayyi A; Richter FC; Scourfield DO; Rehwinkel J; Rodrigues PRS; Davies LC; Gea-Mallorquí E;
    Oxf Open Immunol; 2020; 1(1):iqaa004. PubMed ID: 34192267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune evasion of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2); molecular approaches.
    Ahmadi S; Bazargan M; Elahi R; Esmaeilzadeh A
    Mol Immunol; 2023 Apr; 156():10-19. PubMed ID: 36857806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative review of pathogenesis and host innate immunity evasion strategies among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV).
    Noor R
    Arch Microbiol; 2021 Jul; 203(5):1943-1951. PubMed ID: 33682075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage.
    Amor S; Fernández Blanco L; Baker D
    Clin Exp Immunol; 2020 Nov; 202(2):193-209. PubMed ID: 32978971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion.
    Low ZY; Zabidi NZ; Yip AJW; Puniyamurti A; Chow VTK; Lal SK
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interaction between SARS-CoV-2 and Host Innate Immunity].
    Duan XQ; Xie H; Chen LM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 53(1):1-6. PubMed ID: 35048592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms involved in pathogenicity of SARS-CoV-2: Immune evasion and implications for therapeutic strategies.
    Latifi-Pupovci H
    Biomed Pharmacother; 2022 Sep; 153():113368. PubMed ID: 35792393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N7-Methylation of the Coronavirus RNA Cap Is Required for Maximal Virulence by Preventing Innate Immune Recognition.
    Pan R; Kindler E; Cao L; Zhou Y; Zhang Z; Liu Q; Ebert N; Züst R; Sun Y; Gorbalenya AE; Perlman S; Thiel V; Chen Y; Guo D
    mBio; 2022 Feb; 13(1):e0366221. PubMed ID: 35073761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Nasal and Lung Tissues Infected
    Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG
    J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses.
    Kouwaki T; Nishimura T; Wang G; Oshiumi H
    Front Immunol; 2021; 12():700926. PubMed ID: 34249006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2: A Glance at the Innate Immune Response Elicited by Infection and Vaccination.
    Manfrini N; Notarbartolo S; Grifantini R; Pesce E
    Antibodies (Basel); 2024 Feb; 13(1):. PubMed ID: 38390874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2-mediated evasion strategies for antiviral interferon pathways.
    Oh SJ; Shin OS
    J Microbiol; 2022 Mar; 60(3):290-299. PubMed ID: 35122601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of Innate Immune Activation by Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses.
    Kehrer T; García-Sastre A; Miorin L
    J Interferon Cytokine Res; 2021 Jun; 41(6):205-219. PubMed ID: 34161170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate and adaptive immunity to SARS-CoV-2 and predisposing factors.
    Shen J; Fan J; Zhao Y; Jiang D; Niu Z; Zhang Z; Cao G
    Front Immunol; 2023; 14():1159326. PubMed ID: 37228604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate Immune Evasion by Human Respiratory RNA Viruses.
    Kikkert M
    J Innate Immun; 2020; 12(1):4-20. PubMed ID: 31610541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Infection: Host Response, Immunity, and Therapeutic Targets.
    Shivshankar P; Karmouty-Quintana H; Mills T; Doursout MF; Wang Y; Czopik AK; Evans SE; Eltzschig HK; Yuan X
    Inflammation; 2022 Aug; 45(4):1430-1449. PubMed ID: 35320469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.
    Ahmed-Hassan H; Sisson B; Shukla RK; Wijewantha Y; Funderburg NT; Li Z; Hayes D; Demberg T; Liyanage NPM
    Front Immunol; 2020; 11():1979. PubMed ID: 32973803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon antagonists encoded by SARS-CoV-2 at a glance.
    Lee JH; Koepke L; Kirchhoff F; Sparrer KMJ
    Med Microbiol Immunol; 2023 Apr; 212(2):125-131. PubMed ID: 35366686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of SARS-CoV-2 Evasion: Interferon Pathway and Therapeutic Options.
    Znaidia M; Demeret C; van der Werf S; Komarova AV
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection.
    Totura AL; Whitmore A; Agnihothram S; Schäfer A; Katze MG; Heise MT; Baric RS
    mBio; 2015 May; 6(3):e00638-15. PubMed ID: 26015500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.